GlassScriptPhysician profile
Katrina Wright
NPI 1730497363
$11,520.03
in general payments reported to CMS, 2019-2025
58 companies · $1,988 in 2025
The $1,988 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,632 · 2022: $2,054 · 2023: $2,579 · 2024: $2,268 · 2025: $1,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,637 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,637.40 |
| Education | $196.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,338.71 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,275.75 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $998.96 | 2021-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $690.83 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $637.25 | 2021-2025 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $499.01 | 2021-2024 | Xarelto, Spravato |
| Pfizer INC. | $488.54 | 2021-2025 | |
| Glaxosmithkline, LLC. | $473.56 | 2021-2025 | Trelegy Ellipta, Benlysta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $459.91 | 2021-2025 | |
| Cumberland Pharmaceuticals, INC. | $395.36 | 2021-2023 | Kristalose, Reditrex |
| Abbvie INC. | $353.59 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $347.07 | 2021-2025 | Acthar |
| Altathera Pharmaceuticals LLC | $296.57 | 2023 | Sotalol Hydrochloride |
| Exact Sciences Corporation | $280.35 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $254.61 | 2021-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $225.49 | 2021-2025 | Veozah |
| Janssen Biotech, INC. | $195.25 | 2021-2025 | Tremfya, Stelara, Remicade |
| Ibsa Pharma INC. | $184.25 | 2021-2025 | Tirosint, Tirosint, Licart |
| Esperion Therapeutics, INC. | $177.16 | 2021-2025 | Nexletol |
| Paratek Pharmaceuticals, INC. | $176.73 | 2021-2025 | Nuzyra |
| Jazz Pharmaceuticals INC. | $130.13 | 2021 | |
| Dexcom, INC. | $125.92 | 2021-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.30 | 2021-2024 | Xifaxan |
| Radius Health, INC. | $102.23 | 2022-2025 | |
| Heartflow, INC. | $90.15 | 2023 | Ffrct |
| Corcept Therapeutics | $84.78 | 2025 | Korlym |
| Horizon Therapeutics Plc | $79.83 | 2021-2022 | |
| Ucb, INC. | $74.19 | 2023-2025 | Cimzia, Bimzelx |
| Idorsia Pharmaceuticals US INC | $67.57 | 2023-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $61.08 | 2021-2024 | Capvaxive, Gardasil 9, Gardasil |
| Xeris Pharmaceuticals, INC. | $58.49 | 2024-2025 | Gvoke Hypopen |
| Eisai INC. | $58.22 | 2021 | |
| Phadia US INC. | $53.62 | 2024-2025 | Immunocap |
| Vanda Pharmaceuticals INC. | $53.40 | 2021 | |
| Almatica Pharma LLC | $51.72 | 2023 | Loreev Xr, Sertraline Hcl |
| Aurinia Pharma U.S., INC. | $45.32 | 2022-2023 | Lupkynis |
| Sunovion Pharmaceuticals INC. | $42.94 | 2022 | |
| Intuitive Surgical, INC. | $40.66 | 2022 | |
| Biogen, INC. | $40.08 | 2021 | |
| Insulet Corporation | $37.06 | 2023 | Omnipod |
| Eyevance Pharmaceuticals LLC | $34.78 | 2021 | |
| Mylan Specialty L.P. | $26.55 | 2021 | |
| Endo Pharmaceuticals INC. | $25.92 | 2021 | |
| Medicure Pharma INC. | $24.42 | 2025 | Zypitamag |
| Evoke Pharma, INC. | $22.65 | 2021 | |
| Tonix Medicines, INC. | $22.54 | 2025 | Tonmya |
| Azurity Pharmaceuticals, INC. | $22.16 | 2025 | Alvesco |
| Relievant Medsystems, INC. | $22.08 | 2023 | Intracept |
| Medtronic, INC. | $21.47 | 2025 | Minimed 780g |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 2022 | |
| Amarin Pharma, INC. | $19.44 | 2021 | |
| Optinose US, INC. | $18.67 | 2025 | |
| Sanofi-Aventis U.S. LLC | $16.90 | 2022 | |
| Redhill Biopharma INC. | $14.52 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.37 | 2024 | Purified Cortrophin Gel |
| Vistapharm, INC. | $12.83 | 2021 | |
| Vivus LLC | $8.76 | 2021 | |
| Genentech USA, INC. | $6.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.